Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer
- PMID: 26371775
- DOI: 10.1002/cncr.29693
Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer
Abstract
Background: The emotional status of cancer patients is associated with disease course and treatment outcomes. In this study, the authors evaluated associations between the presence of pretreatment depression and pretreatment quality of life (QOL), nutritional status, and survival outcomes in patients with head and neck squamous cell carcinoma (HNSCC).
Methods: For this prospective study, 241 patients with previously untreated HNSCC who underwent curative treatments were enrolled. Patients completed the Beck Depression Inventory (BDI)-II, the European Organization for Research and Treatment of Cancer (EORTC) 30-item Core QOL Questionnaire (QLQ-C30), and the EORTC QLQ Head and Neck Cancer module (QLQ-H&N35). EORTC QLQ scores were compared between depressive and nondepressive patients, as determined according to pretreatment BDI-II scores ≥ 14 and <14, respectively. Univariate and multivariate analyses were performed to assess whether the presence of depression was associated with overall survival, disease-free survival (DFS), or posttreatment changes in nutritional status and laboratory data.
Results: Pretreatment depression was present in 60 patients (24.9%). In depressive and nondepressive patients, the 3-year overall survival rates were 70.8% and 82.7%, respectively (P = .045), and the 3-year DFS rates were 63.5% and 79.1%, respectively (P = .015). After controlling for clinical factors, the presence of depression was predictive of 3-year DFS (P = .032). EORTC QLQ-C30 and QLQ-HN35 scores on all items except feeding tube, nutritional supplement, and problem with mouth opening differed between depressive and nondepressive patients (P < .05). Depressive patients had lower pretreatment serum albumin levels than nondepressive patients (P < .05).
Conclusions: There was a significant correlation between pretreatment depression and pretreatment QOL, nutritional status, and survival outcomes in patients with HNSCC.
Keywords: depression; head and neck cancer; nutrition; quality of life; survival.
© 2015 American Cancer Society.
Comment in
-
Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.Cancer. 2016 Mar 15;122(6):972-3. doi: 10.1002/cncr.29849. Epub 2015 Dec 22. Cancer. 2016. PMID: 26696264 No abstract available.
-
Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.Cancer. 2016 Mar 15;122(6):971-2. doi: 10.1002/cncr.29850. Epub 2015 Dec 22. Cancer. 2016. PMID: 26696404 No abstract available.
Similar articles
-
Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.Qual Life Res. 2016 Jan;25(1):165-74. doi: 10.1007/s11136-015-1063-y. Epub 2015 Jul 9. Qual Life Res. 2016. PMID: 26156405
-
EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3495-3505. doi: 10.1007/s00405-019-05630-2. Epub 2019 Sep 16. Eur Arch Otorhinolaryngol. 2019. PMID: 31529149
-
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.Eur J Cancer. 2000 Sep;36(14):1796-807. doi: 10.1016/s0959-8049(00)00186-6. Eur J Cancer. 2000. PMID: 10974628
-
Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.Expert Rev Anticancer Ther. 2015 Jan;15(1):109-19. doi: 10.1586/14737140.2015.961427. Epub 2014 Sep 18. Expert Rev Anticancer Ther. 2015. PMID: 25231774 Review.
-
Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck.Curr Opin Oncol. 2000 May;12(3):215-20. doi: 10.1097/00001622-200005000-00006. Curr Opin Oncol. 2000. PMID: 10841193 Review.
Cited by
-
Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer.Adv Ther. 2024 Sep;41(9):3489-3519. doi: 10.1007/s12325-024-02945-3. Epub 2024 Aug 7. Adv Ther. 2024. PMID: 39110309 Free PMC article.
-
Ethical considerations in screening head and neck cancer patients for psychosocial distress.Support Care Cancer. 2020 Feb;28(2):617-624. doi: 10.1007/s00520-019-04860-8. Epub 2019 May 20. Support Care Cancer. 2020. PMID: 31111246
-
Major Depression and Survival in People With Cancer.Psychosom Med. 2021 Jun 1;83(5):410-416. doi: 10.1097/PSY.0000000000000942. Psychosom Med. 2021. PMID: 33938501 Free PMC article.
-
Cohort study of oncologic emergencies in patients with head and neck cancer.Head Neck. 2017 Jun;39(6):1195-1204. doi: 10.1002/hed.24748. Epub 2017 Mar 27. Head Neck. 2017. PMID: 28346771 Free PMC article.
-
Depression and survival in head and neck cancer patients.Oral Oncol. 2017 Feb;65:76-82. doi: 10.1016/j.oraloncology.2016.12.014. Epub 2017 Jan 1. Oral Oncol. 2017. PMID: 28109472 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical